Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zai Lab's share price for the quarter that ended in Dec. 2023 was $27.33. Zai Lab's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 97.2 Mil. Therefore, Zai Lab's market cap for the quarter that ended in Dec. 2023 was $2,657.1 Mil.
Zai Lab's quarterly market cap
declined
from Jun. 2023 ($2,685.8 Mil) to Sep. 2023 ($2,355.7 Mil) but then
increased
from Sep. 2023 ($2,355.7 Mil) to Dec. 2023 ($2,657.1 Mil).
Zai Lab's annual market cap
declined
from Dec. 2021 ($6,002.1 Mil) to Dec. 2022 ($2,947.9 Mil) and
declined
from Dec. 2022 ($2,947.9 Mil) to Dec. 2023 ($2,657.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zai Lab's Enterprise Value for Today is $810.1 Mil.
Zai Lab Market Cap Historical Data
The historical data trend for Zai Lab's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zai Lab's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zai Lab's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zai Lab's Market Cap distribution charts can be found below:
* The bar in red indicates where Zai Lab's Market Cap falls into.
Zai Lab Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zai Lab's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zai Lab (NAS:ZLAB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zai Lab Market Cap Related Terms
Thank you for viewing the detailed overview of Zai Lab's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZLAB has been successfully added to your 